After witnessing a decline in the price value of Minoxidil during January, its demand has now gained momentum again in both developed and emerging markets including China, India, Germany and the US. Declining inflationary and recessionary pressure is positively affecting the consumer confidence across the globe, further supporting the market dynamics of several pharmaceutical APIs such as Minoxidil.

In the Asian markets, the prices of Minoxidil improved throughout February on the account of increase in buying activity owing to which market participants raised their quotations of all piled up inventories since November 2022. The global trading environment has also improved, which has boosted exports significantly and supported the upward price trend in both India and China. Also, a steady increase in demand from the downstream sectors and a sharp increase in overseas enquiries have prompted manufacturers to begin their industrial manufacturing locally to cope up with flowed up requirements.

In Germany and the US, pricing trends for Minoxidil were similar to that observed in the Asian markets. According to one of the most recent studies, Minoxidil API has become increasingly popular as an alternative hair loss treatment that has helped many cancer patients, which has led to an increase in demand for the drug and its upstream requirements. Low-dose oral Minoxidil is also seen to represent the future of hair loss/Alopecia due to the expanding market and opportunities in the pharmaceutical sector. The market sentiments for Minoxidil in Europe remained upbeat considering improvements in downstream sector procurement and needs.

According to ChemAnalyst, it is projected that the prices of Minoxidil will remain on the upper side across the globe. Demand from the domestic and international market is likely to support this trend in forthcoming months as well. On the top of that, the cost of raw materials is estimated to increase for the majority of Active Pharmaceutical Ingredients, including Minoxidil, signalling a favourable trend for the pharmaceutical and healthcare industries as well as demand in both the local and global markets.